Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 6/2016

01-06-2016 | Original Article

Absence of a Periampullary Mass on Cross-sectional Imaging Delays Diagnosis and Time to Pancreatoduodenectomy But Does Not Impair Outcome

Authors: Hideo Takahashi, Maitham A. Moslim, Naftali Presser, Colin O’Rourke, Jane Wey, Sricharan Chalikonda, Matthew R. Walsh, Gareth Morris-Stiff

Published in: Journal of Gastrointestinal Surgery | Issue 6/2016

Login to get access

Abstract

Background

The aim of this study was to assess whether the lack of a radiological mass in patients with periampullary malignancies led to protracted diagnosis, delayed resection, and an inferior outcome.

Methods

The departmental database was interrogated to identify all patients undergoing pancreatoduodenectomy during the period 2000–2014. The absence of a mass on cross-sectional and endoscopic ultrasound was noted. The interval between imaging and surgery was evaluated and related to the absence of a mass. The relationship between mass/no mass and the pathological profile was also assessed.

Results

Among 490 patients who underwent pancreatoduodenectomy for periampullary malignancies, masses were detected in 299 patients. Patients with undetected mass on either endoscopic ultrasonography (EUS) or computed tomography (CT)/magnetic resonance imaging (MRI) had a longer median interval from initial imaging to resection than detected mass with no difference in survival (66 vs. 41 days, p = 0.001). The absence of a mass was more common in cholangiocarcinomas (p < 0.001). The absence of a mass on imaging was associated with smaller size on final histopathology (2.4 vs. 2.8 cm; p < 0.001).

Conclusions

The absence of a mass with all modalities in patients with a periampullary malignancy leads to a delayed diagnosis without a significant effect on survival.
Literature
1.
go back to reference Asbun HJ, Conlon K, Fernandez-Cruz L, Friess H et al. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery 2014;155:887–92CrossRefPubMed Asbun HJ, Conlon K, Fernandez-Cruz L, Friess H et al. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery 2014;155:887–92CrossRefPubMed
2.
go back to reference Conrad C, Fernández-Del Castillo C. Preoperative evaluation and management of the pancreatic head mass. J Surg Oncol 2013;107:23–32CrossRefPubMed Conrad C, Fernández-Del Castillo C. Preoperative evaluation and management of the pancreatic head mass. J Surg Oncol 2013;107:23–32CrossRefPubMed
4.
5.
go back to reference Anderson SW, Zajick D, Lucey BC, Soto JA. 64-detector row computed tomography: an improved tool for evaluating the biliary and pancreatic ducts? Curr Probl Diagn Radiol. 2007:36:258–71CrossRefPubMed Anderson SW, Zajick D, Lucey BC, Soto JA. 64-detector row computed tomography: an improved tool for evaluating the biliary and pancreatic ducts? Curr Probl Diagn Radiol. 2007:36:258–71CrossRefPubMed
6.
go back to reference Delbeke D, Martin WH. PET and PET/CT for pancreatic malignancies. Surg Oncol Clin N Am. 2010;19:235–54CrossRefPubMed Delbeke D, Martin WH. PET and PET/CT for pancreatic malignancies. Surg Oncol Clin N Am. 2010;19:235–54CrossRefPubMed
7.
go back to reference Pakzad F, Groves AM, Ell PJ. The role of positron emission tomogramphy in the management of pancreatic cancer. Semin Nucl Med. 2006;36:248–56CrossRefPubMed Pakzad F, Groves AM, Ell PJ. The role of positron emission tomogramphy in the management of pancreatic cancer. Semin Nucl Med. 2006;36:248–56CrossRefPubMed
8.
go back to reference Gerritsen A, Bollen TL, Nio CY, Molenaar IQ, Dijkgraaf MG, van Santvoort HC, Offerhaus GJ, Brosens LA, Biermann K, Sieders E., de Jong KP, van Dam RM, van der Harst E, van Goor H, van Ramshorst B, Bonsing BA, de Hingh IH, Gerhards MF, van Eijck CH, Gouma DJ, Borel Rinkes IH, Busch OR, Besselink MG, Dutch Pancreatic Cancer Group. Diagnostic value of a pancreastic mass on computed tomography in patients undergoing pancreatoduodenectomy for presumed pancreatic cancer. Surgery 2015;158:173–82CrossRefPubMed Gerritsen A, Bollen TL, Nio CY, Molenaar IQ, Dijkgraaf MG, van Santvoort HC, Offerhaus GJ, Brosens LA, Biermann K, Sieders E., de Jong KP, van Dam RM, van der Harst E, van Goor H, van Ramshorst B, Bonsing BA, de Hingh IH, Gerhards MF, van Eijck CH, Gouma DJ, Borel Rinkes IH, Busch OR, Besselink MG, Dutch Pancreatic Cancer Group. Diagnostic value of a pancreastic mass on computed tomography in patients undergoing pancreatoduodenectomy for presumed pancreatic cancer. Surgery 2015;158:173–82CrossRefPubMed
10.
go back to reference Rösch T, Braig C, Gain T, Feuerbach S, Siewert JR, Schusdziarra V, Classen M. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992;102:188–99PubMed Rösch T, Braig C, Gain T, Feuerbach S, Siewert JR, Schusdziarra V, Classen M. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992;102:188–99PubMed
11.
go back to reference Cahn M, Chang K, Nguyen P, Butler J. Impact of endoscopic ultrasound with fine-needle aspiration on the surgicall management of pancreatic cancer. Am J Surg 1996;172:470–2CrossRefPubMed Cahn M, Chang K, Nguyen P, Butler J. Impact of endoscopic ultrasound with fine-needle aspiration on the surgicall management of pancreatic cancer. Am J Surg 1996;172:470–2CrossRefPubMed
12.
go back to reference Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Chamsangavej C. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging 2007;32:660–7CrossRefPubMed Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Chamsangavej C. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging 2007;32:660–7CrossRefPubMed
13.
go back to reference Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monahan KJ. EUS-guided FNA for diagnosis of sold pancreastic neoplasms: a meta-analysis. Gastrointest Endosc 2012;75:319–31CrossRefPubMed Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monahan KJ. EUS-guided FNA for diagnosis of sold pancreastic neoplasms: a meta-analysis. Gastrointest Endosc 2012;75:319–31CrossRefPubMed
14.
go back to reference Müller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT and MRI imaging. Radiology 1994;190:745–51CrossRefPubMed Müller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT and MRI imaging. Radiology 1994;190:745–51CrossRefPubMed
15.
go back to reference Deerenberg EB, Poley JW, Hermans JJ, Ganesh S, van der Harst E, van Eijck CH. Role of endoscopic ultrasonography in patients suspected of pancreatic cancer with negative helical MDCT scan. Dig Surg 2011;28:398–403CrossRefPubMed Deerenberg EB, Poley JW, Hermans JJ, Ganesh S, van der Harst E, van Eijck CH. Role of endoscopic ultrasonography in patients suspected of pancreatic cancer with negative helical MDCT scan. Dig Surg 2011;28:398–403CrossRefPubMed
16.
go back to reference Wang W, Shpaner A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, Raju GS, Xiao L, Wolff RA, Fleming JB, Lee JH. Use of EUS-FNA in diagnosing pancreastic neoplasm without definitive mass on CT. Gastrointest Endosc 2013;78:73–80CrossRefPubMed Wang W, Shpaner A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, Raju GS, Xiao L, Wolff RA, Fleming JB, Lee JH. Use of EUS-FNA in diagnosing pancreastic neoplasm without definitive mass on CT. Gastrointest Endosc 2013;78:73–80CrossRefPubMed
17.
go back to reference Tummala P, Munigala S, Eloubeidi MA, Agarwal B. Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA. J Clin Gastroenterol 2013;47:532–7CrossRefPubMed Tummala P, Munigala S, Eloubeidi MA, Agarwal B. Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA. J Clin Gastroenterol 2013;47:532–7CrossRefPubMed
18.
go back to reference Hennedige TP, Neo WT, Venkatesh SK. Imaging of malignancies of the biliary tract—an update. Cancer Imaging 2014;14:14PubMedPubMedCentral Hennedige TP, Neo WT, Venkatesh SK. Imaging of malignancies of the biliary tract—an update. Cancer Imaging 2014;14:14PubMedPubMedCentral
20.
go back to reference Kooby DA, Lad NL, Squires MH 3rd, Maithel SK, Sarmiento JM, Staley CA, Adsay NV, El-Rayes BF, Weber SM, Winslow ER, Cho CS, Zavala KA, Bentrem DJ, Knab M, Ahmad SA, Abbott DE, Sutton JM, Kim HJ, Yeh JJ, Aufforth R, Scoggins CR, Martin RC, Parikh AA, Robinson J, Hashim YM, Fields RC, Hawkins WG, Merchant NB. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients. Ann Surg 2014;260:494–503CrossRefPubMed Kooby DA, Lad NL, Squires MH 3rd, Maithel SK, Sarmiento JM, Staley CA, Adsay NV, El-Rayes BF, Weber SM, Winslow ER, Cho CS, Zavala KA, Bentrem DJ, Knab M, Ahmad SA, Abbott DE, Sutton JM, Kim HJ, Yeh JJ, Aufforth R, Scoggins CR, Martin RC, Parikh AA, Robinson J, Hashim YM, Fields RC, Hawkins WG, Merchant NB. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients. Ann Surg 2014;260:494–503CrossRefPubMed
21.
go back to reference Yarandi SS, Runge T, Wang L, Liu Z, Jiang Y, Chawla S, Woods KE, Willingham FF, Xu H, Cai Q. Increased incidence of benign pancreatic pathology following pancreaticoduodenectomy for presumed malignancy over 10 years despite increased use of endoscopic ultrasound. Diagn Ther Endosc 2014;p.701535 Yarandi SS, Runge T, Wang L, Liu Z, Jiang Y, Chawla S, Woods KE, Willingham FF, Xu H, Cai Q. Increased incidence of benign pancreatic pathology following pancreaticoduodenectomy for presumed malignancy over 10 years despite increased use of endoscopic ultrasound. Diagn Ther Endosc 2014;p.701535
22.
go back to reference Wojcicki J, Zen Y, Peddu P, Jain R, Patel AG, Atkinson S, Srinivasan P, Rela M, Heaton N, Prachalias A. Benign histology after pancreaticoduodenectomy for suspected malignancy. Lessons to be learned—a single centre experience. Pol Przegi Chir 2015;87:6–15 Wojcicki J, Zen Y, Peddu P, Jain R, Patel AG, Atkinson S, Srinivasan P, Rela M, Heaton N, Prachalias A. Benign histology after pancreaticoduodenectomy for suspected malignancy. Lessons to be learned—a single centre experience. Pol Przegi Chir 2015;87:6–15
Metadata
Title
Absence of a Periampullary Mass on Cross-sectional Imaging Delays Diagnosis and Time to Pancreatoduodenectomy But Does Not Impair Outcome
Authors
Hideo Takahashi
Maitham A. Moslim
Naftali Presser
Colin O’Rourke
Jane Wey
Sricharan Chalikonda
Matthew R. Walsh
Gareth Morris-Stiff
Publication date
01-06-2016
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 6/2016
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-016-3127-x

Other articles of this Issue 6/2016

Journal of Gastrointestinal Surgery 6/2016 Go to the issue